Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 30 Men only

Alcohol and sexual health education for young men

Official title: Advancing New Computer-based Health Outreach Regarding Sexual Behavior (ANCHORS) Study: UH3 Project

Run by University of Florida · NCT04331704 · Data updated 2026-11-12

This study is testing whether different types of education on alcohol and sexual health can help young men stay safe from alcohol-related problems and STIs while they use a preventive HIV medication.

More Substance Use trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 30 Years
SexMen only
Enrollment88 (estimated)
SponsorUniversity of Florida
Academic / other
Locations1 site (Gainesville, Florida)
StatusRecruiting
StartedJanuary 12, 2021
Main results expectedDecember 31, 2025
Study endsJune 30, 2026
Registry record updatedJuly 10, 2025
Trial IDNCT04331704 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are young adult men who consume alcohol heavily and engage in unprotected sexual intercourse.

Probably not a fit

Patients with a history of severe alcohol withdrawal or those with serious psychiatric symptoms may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves 80 young adult men who will complete an initial survey and receive one of two types of education on alcohol and sexual health to help prevent alcohol-related issues, HIV, and other STIs. Participants will take pre-exposure prophylaxis (PrEP) for HIV prevention and engage in a daily 5-minute telephone-based interactive voice response (IVR) assessment of their alcohol and substance use, sexual behavior, and PrEP adherence for 30 days. Follow-up assessments will occur at 30 days and again at 6 months to evaluate the effectiveness of the interventions.

Why it matters

Potential benefit: If successful, this study could significantly reduce the risk of alcohol-related problems and HIV transmission among young men.

How similar studies have gone: Other studies have shown success with similar educational interventions aimed at reducing alcohol-related risks and improving PrEP adherence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ability to read and write English
* Consumption of 5 or more drinks per drinks in a day at least once in the past 30-days
* Sexual intercourse with another man without condom use at least once in the past 30 days
* HIV seronegative at medical screening
* Report currently taking PrEP willingness to take PrEP

Exclusion Criteria:

* History of clinically significant withdrawal from alcohol, defined as any one of the following: a) a lifetime history of seizures, delirium, or hallucinations during alcohol withdrawal; b) a Clinical Institute Withdrawal Assessment scale score \> 8; c) a report of drinking to avoid withdrawal symptoms in the past 12 months; or d) a lifetime history of medical treatment for withdrawal.
* Self report injection drug use
* DSM-5 criteria for moderate or severe current substance use disorder besides alcohol and nicotine.
* Serious psychiatric symptoms
* Use of medications that interfere with PrEP including diuretics, nephrotoxic drugs, non-steroidal anti-inflammatory drugs, antiretroviral drugs or other drugs that may interfere with tenofovir excretion
* Active hepatitis B infection
* The following medical exclusions: serious or life-threatening conditions; inadequate biochemical, hepatic, hematologic, or pancreatic function according to laboratory testing
* Participant reports currently taking injectable PrEP

Where it's running

  • University of Florida
    Gainesville, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Robert L. Cook, PhD — University of Florida
  • Study coordinator: Robert L. Cook, PhD
  • Email: cookrl@ufl.edu
  • Phone: (352) 273-5869

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.